{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:24:20Z","timestamp":1790846660198,"version":"4.1.0"},"reference-count":43,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"unspecified","delay-in-days":8194,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[1987,2]]},"abstract":"<jats:title>Synopsis<\/jats:title><jats:p>In three studies of comparable design, 47 schizophrenics received anticholinergic anti-Parkinsonism (AP) medications for two to four weeks along the course of neuroleptic treatment. Clinical ratings during the AP phase were contrasted against the preceding and following two-week periods on neuroleptic alone, and these changes were analysed for a total of 27 psychopathology dimensions and for clusters of seven positive and seven negative symptoms. Schizophrenics overall exhibited significant exacerbation of total psychopathology, and positive but not negative symptoms. Only those with a predominantly positive syndrome when drug-free were susceptible to AP therapeutic reversal. However, other subgroup analyses revealed worsening of total psychopathology and positive symptoms among catatonic, schizophreniform, chronic, and good outcome cases, but negative symptoms alone were significantly increased among paranoids. The results were not supportive of a positive\u2013negative dichotomy of schizophrenia, but instead suggested a tripartite model: a distinct paranoid group and a division of the non-paranoids into a positive and a negative type.<\/jats:p>","DOI":"10.1017\/s0033291700012964","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T14:41:21Z","timestamp":1247150481000},"page":"39-48","source":"Crossref","is-referenced-by-count":41,"title":["Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping"],"prefix":"10.1017","volume":"17","author":[{"given":"Man Mohan","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley R.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis A.","family":"Opler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"S0033291700012964_ref037","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-1218-5_9"},{"key":"S0033291700012964_ref043","volume-title":"Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders","author":"Spitzer","year":"1978"},{"key":"S0033291700012964_ref031","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.194.4263.449","article-title":"Wheat gluten \u2013 schizophrenia findings","volume":"194","author":"Singh","year":"1976","journal-title":"Science"},{"key":"S0033291700012964_ref032","doi-asserted-by":"publisher","DOI":"10.1159\/000117643"},{"key":"S0033291700012964_ref009","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700047942"},{"key":"S0033291700012964_ref021","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(84)90080-4"},{"key":"S0033291700012964_ref039","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(81)90046-9"},{"key":"S0033291700012964_ref038","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421208"},{"key":"S0033291700012964_ref035","first-page":"277","article-title":"Dysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosis","volume":"14","author":"Singh","year":"1979","journal-title":"Biological Psychiatry"},{"key":"S0033291700012964_ref034","doi-asserted-by":"publisher","DOI":"10.1159\/000117667"},{"key":"S0033291700012964_ref033","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/4.1.3"},{"key":"S0033291700012964_ref024","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198406000-00002"},{"key":"S0033291700012964_ref023","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1965.tb04996.x"},{"key":"S0033291700012964_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(86)90003-9"},{"key":"S0033291700012964_ref019","volume-title":"Schizophreniform States: A Katamnestic Study Based on Individual Re-examinations","author":"Langfeldt","year":"1939"},{"key":"S0033291700012964_ref017","article-title":"Significance of positive and negative syndromes in chronic schizophrenia","volume":"148","author":"Kay","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"S0033291700012964_ref016","first-page":"155","article-title":"Cognitive abnormality in schizophrenia: A dual-process model","volume":"14","author":"Kay","year":"1979","journal-title":"Biological Psychiatry"},{"key":"S0033291700012964_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90054-7"},{"key":"S0033291700012964_ref008","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.1.39"},{"key":"S0033291700012964_ref007","first-page":"213","article-title":"Intensity and equivalence of neuroleptic effect and its therapeutic importance","volume":"33","author":"Haase","year":"1962","journal-title":"Nervenarzt"},{"key":"S0033291700012964_ref005","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-05932-4_8"},{"key":"S0033291700012964_ref015","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1975.tb00195.x"},{"key":"S0033291700012964_ref006","first-page":"434","volume-title":"Neuroregulators and Psychiatric Disorders","author":"Davis","year":"1977"},{"key":"S0033291700012964_ref026","doi-asserted-by":"publisher","DOI":"10.1126\/science.504988"},{"key":"S0033291700012964_ref030","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197504000-00005"},{"key":"S0033291700012964_ref036","first-page":"93","volume-title":"Psychobiology of Schizophrenia","author":"Singh","year":"1982"},{"key":"S0033291700012964_ref012","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198203000-00004"},{"key":"S0033291700012964_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90193-9"},{"key":"S0033291700012964_ref014","doi-asserted-by":"publisher","DOI":"10.2466\/pms.1975.40.1.178"},{"key":"S0033291700012964_ref002","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433802"},{"key":"S0033291700012964_ref027","volume-title":"Schizophrenia, Selected Papers","author":"Shakow","year":"1977"},{"key":"S0033291700012964_ref040","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198108000-00006"},{"key":"S0033291700012964_ref022","first-page":"1269","article-title":"Hemispheric preference of paranoid and nonparanoid schizophrenics","volume":"18","author":"Magaro","year":"1983","journal-title":"Biological Psychiatry"},{"key":"S0033291700012964_ref028","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421012"},{"key":"S0033291700012964_ref042","volume-title":"Psychiatric Evaluation Form \u2013 R2. Manual of Instructions","author":"Spitzer","year":"1969"},{"key":"S0033291700012964_ref003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1960.tb07611.x"},{"key":"S0033291700012964_ref013","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.125.2.146"},{"key":"S0033291700012964_ref004","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/S0007125000071919","article-title":"Positive and negative schizophrenic symptoms and the role of dopamine","volume":"137","author":"Crow","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"S0033291700012964_ref001","volume-title":"Diagnostic and Statistical Manual of Psychiatric Disorders","year":"1980"},{"key":"S0033291700012964_ref029","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421013"},{"key":"S0033291700012964_ref018","doi-asserted-by":"publisher","DOI":"10.1126\/science.7350667"},{"key":"S0033291700012964_ref041","volume-title":"Clinical Psychiatry","author":"Slater","year":"1969"},{"key":"S0033291700012964_ref025","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291700012964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T09:44:09Z","timestamp":1633686249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291700012964\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987,2]]}},"alternative-id":["S0033291700012964"],"URL":"https:\/\/doi.org\/10.1017\/s0033291700012964","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,2]]}}}